Xiaoling Wang
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- Metal complexes synthesis and properties
- Pancreatic and Hepatic Oncology Research
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 19
- Metal complexes synthesis and properties 4
- Pancreatic and Hepatic Oncology Research 3
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 3
-
- Crystal structures of chemical compounds 6
- Co-authors
- Zhanjun Guo (4 shared papers)Ruixing Zhang (3 shared papers)Zhong‐Lu You (5 shared papers)Baoen Shan (2 shared papers)Cui-ju Wang (1 shared paper)Da‐Hua Shi (2 shared papers)Jin Liu (1 shared paper)Wenxue Chen (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)International Journal of Cancer (2 papers)Journal of Clinical Investigation (1 paper)BMC Cancer (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xiaoling Wang
53 papers receiving 672 citations
Peers
Comparison fields: 5 of 66
- Geriatrics and Gerontology 46
- Oncology 173
- Cancer Research 85
- Inorganic Chemistry 54
- Drug Discovery 1
Countries citing papers authored by Xiaoling Wang
This map shows the geographic impact of Xiaoling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Wang more than expected).
Fields of papers citing papers by Xiaoling Wang
This network shows the impact of papers produced by Xiaoling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Wang. The network helps show where Xiaoling Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 57 | |
| 2 | 2013 | 46 | |
| 3 | 2010 | 44 | |
| 4 | 2007 | 39 | |
| 5 | 2010 | 37 | |
| 6 | 2016 | 34 | |
| 7 | 2016 | 31 | |
| 8 | 2011 | 27 | |
| 9 | 2013 | 25 | |
| 10 | 2013 | 22 | |
| 11 | 2020 | 18 | |
| 12 | 2011 | 17 | |
| 13 | 2012 | 17 | |
| 14 | 2020 | 17 | |
| 15 | 2022 | 17 | |
| 16 | Younger age of onset and multiple primary lesions associated with esophageal squamous cell carcinoma cases with a positive family history of the cancer suggests genetic predisposition. | 2014 | 13 |
| 17 | 2019 | 13 | |
| 18 | 2011 | 12 | |
| 19 | 2022 | 12 | |
| 20 | 2008 | 11 |
About Xiaoling Wang
Xiaoling Wang is a scholar working on Oncology, Inorganic Chemistry, Hepatology, Surgery and Geriatrics and Gerontology, having authored 55 papers that have together received 687 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (7 papers), Crystal structures of chemical compounds (6 papers), Metal complexes synthesis and properties (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Cells and Metastasis (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), HER2/EGFR in Cancer Research (3 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Geriatrics and Gerontology (46 citations), Oncology (173 citations), Cancer Research (85 citations), Inorganic Chemistry (54 citations) and Drug Discovery (1 citation). Xiaoling Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhanjun Guo, Ruixing Zhang, Zhong‐Lu You, Baoen Shan, Cui-ju Wang, Da‐Hua Shi, Jin Liu, Wenxue Chen, Yue Zhao and Xiaofang Li. Their work appears in journals such as Frontiers in Oncology, International Journal of Cancer, Journal of Clinical Investigation, BMC Cancer and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.